Aβ-Protein Inhibitors Reshaping Alzheimer’s Disease Treatment and Drug Development
The Changing Alzheimer’s Disease Treatment Landscape Alzheimer’s disease treatment has increasingly shifted from managing symptoms toward disease modification, particularly with therapies designed to target amyloid-beta (Aβ), a protein associated with plaque accumulation in the brain. The development of amyloid beta inhibitors has provided clinical evidence that removing...
0 Commentaires 0 Parts 3 Vue 0 Aperçu